News & Updates

Show Multimedia Only
Benralizumab offers sustained remission in severe eosinophilic asthma

Benralizumab offers sustained remission in severe eosinophilic asthma

30 Sep 2024 byStephen Padilla

Treatment with benralizumab (BRZ) results in sustained remission in patients with severe eosinophilic asthma (SEA), particularly those with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) and reversible airflow limitation, reports a study.

30 Sep 2024
Autism risk in children not heightened by COVID-19 pandemic exposure

Autism risk in children not heightened by COVID-19 pandemic exposure

29 Sep 2024 byJairia Dela Cruz

Children born during the COVID-19 pandemic or to mothers with history of prenatal SARS-CoV-2 infection are not at increased risk of autism compared with their counterparts who were born before the pandemic or have no exposure to maternal SARS-CoV-2 infection, as reported in a cohort study.

29 Sep 2024
Long-term bulevirtide use safe, efficacious in chronic HDV

Long-term bulevirtide use safe, efficacious in chronic HDV

29 Sep 2024 byStephen Padilla

Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.

29 Sep 2024